ArticleFrontiers in oncology2021

Nivolumab and Hypofractionated Radiotherapy in Patients With Advanced Lung Cancer: ABSCOPAL-1 Clinical Trial.

Hua Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.